Browsing: reports

This is a paid press release. Contact the press release distributor directly with any inquiries.

Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), a clinical-stage biopharmaceutical company developing innovative products focused on the treatment or prevention of gastrointestinal cancers, today announces its unaudited interim results for the six months ended June 30, 2026 which will also be made available on the Company’s website at https://biodexapharma.com/ .

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Raising full year guidance following strong operating performance and positive start to third quarter

South Africa, Sept. 09, 2026 (GLOBE NEWSWIRE) — Lesaka Technologies, Inc. (Nasdaq: LSAK; JSE: LSK) today released results for the fourth quarter (“Q4 2026”) and full year of fiscal 2026 (“FY2026”)

Every major analytics modernization effort shares the same aspiration: Replace static reports with AI-powered insights, give executives answers instead of data, and make intelligence conversational.